BioCatalyst

CORT — CORCEPT THERAPEUTICS INC catalysts

2 verified catalyst event(s) for CORCEPT THERAPEUTICS INC (ticker CORT). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-10-01 — Dazucorilant in Patients With Amyotrophic Lateral Sclerosis · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 11d
ESTIMATED
 READOUT
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
Phase 2 · Amyotrophic Lateral Sclerosis
 CORT CORCEPT THERAPEUTICS INC Dazucorilant 300 mg, Dazucorilant 150 mg ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12 (month)
in 2mo
ESTIMATED
 READOUT
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patie
Phase 2 · Cushing Syndrome
 CORT CORCEPT THERAPEUTICS INC relacorilant ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.